Do You Still Have A Reason To Buy Entero Therapeutics Inc (NASDAQ: ENTO) After A -6.15% Drop In The Last Week?
During the last session, Entero Therapeutics Inc (NASDAQ:ENTO)’s traded shares were 95416.0, with the beta value of the company hitting 0.80. The 52-week high for